Citation Impact
Citing Papers
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients
2011
Pulmonary atresia with intact ventricular septum
2002
Early Bronchiolitis Obliterans Following Lung Transplantation: Accuracy of Expiratory Thin-Section CT for Diagnosis
2000
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
2018 Standout
Outcome in Cyanotic Neonates With Ebstein’s Anomaly
1998
Bronchiolitis Obliterans After Lung Transplantation
1998
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Results After Surgical Repair of Ebstein’s Anomaly
1997
DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME IN RECIPIENTS OF HEART-LUNG TRANSPLANTATION-EARLY RISK FACTORS
1996
Surveillance Bronchoscopy in Lung Transplant Recipients: Risk versus Benefit
2008
Obliterative bronchiolitis after lung and heart-lung transplantation
1995
User-Centered Design and Interactive Health Technologies for Patients
2009 Standout
Microemulsion-based media as novel drug delivery systems
2000 Standout
Pulmonary Capillaritis in Lung Transplant Recipients: Treatment and Effect on Allograft Function
2005
Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation?
2004
Bronchiolitis Obliterans After Lung Transplantation
1998
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
1996
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
Persistent Increases of BAL Neutrophils as a Predictor of Mortality Following Lung Transplant
1999
Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung
1998
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Treatment of presumed and proven acute rejection following six months of lung transplant survival.
1995
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
LUNG TRANSPLANTATION FOR PRIMARY PULMONARY HYPERTENSION
2001
Early and medium-term results for repair of ebstein anomaly
2004
Small airways diseases: detection and insights with computed tomography
2001
Chronic graft-versus-host disease
2003 Standout
Lung Transplantation for Cystic Fibrosis
1996
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Nontuberculous Mycobacteria in Solid Organ Transplant Recipients
2009
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE (NEORAL) AND SDZ RAD IN NON-HUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMACOKINETIC-BASED TRIALS TO IMPROVE EFFICACY AND TOLERABILITY 1
2000
Prevalence of congenital heart disease
2004 Standout
Nocardiosis at the Turn of the Century
2009 Standout
Outcome in neonates with Ebstein's anomaly
1992
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Infections Due to Nontuberculous Mycobacteria in Kidney, Heart, and Liver Transplant Recipients
1994
The incidence of congenital heart disease
2002 Standout
Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
1997
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
2002 Standout
Hydrogen sulphide and its therapeutic potential
2007 Standout
Fleischner Society: Glossary of Terms for Thoracic Imaging
2008 Standout
Chronic Lung Allograft Rejection: Mechanisms and Therapy
2009
Excellent long-term functional outcome after an operation for anomalous left coronary artery from the pulmonary artery
1999
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Ebstein's anomaly: Presentation and outcome from fetus to adult
1994
Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients
2002
Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A
1994
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The therapeutic potential of carbon monoxide
2010 Standout
Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant
1999
Mycobacterium scrofulaceum Infection Presenting as Lung Nodules in a Heart Transplant Recipient
1994
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Detection of Obliterative Bronchiolitis after Lung Transplantation by Indexes of Ventilation Distribution
2000
Early Detection of Airway Involvement in Obliterative Bronchiolitis after Lung Transplantation
2000
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation
1997
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Infections in solid-organ transplant recipients
1997
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Water Microbiology. Bacterial Pathogens and Water
2010 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Bronchiolitis Obliterans: Pathogenesis, Prevention, and Management
1998
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The isolation and identification ofMycobacterium aviumcomplex (MAC) recovered from Los Angeles potable water, a possible source of infection in AIDS patients
1994
Aspergillus fumigatusand Aspergillosis
1999 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Comparison of Large Restriction Fragments of Mycobacterium avium Isolates Recovered from AIDS and Non-AIDS Patients with Those of Isolates from Potable Water
1999
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients
1995
Ebstein’s Anomaly
2007
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Cardiac Transplantation for Kawasaki Disease
1997
Works of Starnes Va being referenced
Distribution of TCR alpha beta+ and TCR gamma delta+ lymphocytes in bronchoalveolar lavage from human lung transplant recipients.
1993
The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy.
1993
Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience.
1990
Heart transplantation in children.
1989
Living-related lobar transplantation: recipient outcome and early rejection patterns.
1995
The role of transbronchial biopsies in the management of lung transplant recipients.
1993
Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
1989
Ebstein's anomaly appearing in the neonate. A new surgical approach.
1991